162 related articles for article (PubMed ID: 35697299)
21. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
[TBL] [Abstract][Full Text] [Related]
22. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
[TBL] [Abstract][Full Text] [Related]
24. Interaction analysis of gene variants of TCF7L2 and body mass index and waist circumference on type 2 diabetes.
Li L; Wang J; Ping Z; Li Y; Wang C; Shi Y; Zhou W; Zhang L
Clin Nutr; 2020 Jan; 39(1):192-197. PubMed ID: 30718095
[TBL] [Abstract][Full Text] [Related]
25. The Role of
Del Bosque-Plata L; Martínez-Martínez E; Espinoza-Camacho MÁ; Gragnoli C
Diabetes; 2021 Jun; 70(6):1220-1228. PubMed ID: 34016596
[No Abstract] [Full Text] [Related]
26. TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome.
Katsoulis K; Paschou SA; Hatzi E; Tigas S; Georgiou I; Tsatsoulis A
Hormones (Athens); 2018 Sep; 17(3):359-365. PubMed ID: 29971604
[TBL] [Abstract][Full Text] [Related]
27. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
28. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
[TBL] [Abstract][Full Text] [Related]
29. Interrelationship of the rs7903146 TCF7L2 gene variant with measures of glucose metabolism and adiposity: The NEO study.
Noordam R; Zwetsloot CPA; de Mutsert R; Mook-Kanamori DO; Lamb HJ; de Roos A; de Koning EJP; Rosendaal FR; Willems van Dijk K; van Heemst D
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):150-157. PubMed ID: 29174029
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of the rs7903146C>T polymorphism in TCF7L2 gene for prediction of type 2 diabetes risk among Iranians of different ethnicities.
Allahdini M; Kamalidehghan B; Akbari L; Azadfar P; Rahmani A; Ahmadipour F; Meng GY; Masserrat A; Houshmand M
Drug Des Devel Ther; 2015; 9():5835-41. PubMed ID: 26604685
[TBL] [Abstract][Full Text] [Related]
31. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
[TBL] [Abstract][Full Text] [Related]
32. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
33. The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes.
Del Bosque-Plata L; Hernández-Cortés EP; Gragnoli C
J Cell Physiol; 2022 Jan; 237(1):301-312. PubMed ID: 34612510
[TBL] [Abstract][Full Text] [Related]
34. Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells.
Bagchi DP; Nishii A; Li Z; DelProposto JB; Corsa CA; Mori H; Hardij J; Learman BS; Lumeng CN; MacDougald OA
Mol Metab; 2020 Dec; 42():101078. PubMed ID: 32919095
[TBL] [Abstract][Full Text] [Related]
35. LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion.
Loh NY; Neville MJ; Marinou K; Hardcastle SA; Fielding BA; Duncan EL; McCarthy MI; Tobias JH; Gregson CL; Karpe F; Christodoulides C
Cell Metab; 2015 Feb; 21(2):262-273. PubMed ID: 25651180
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor 7-like 2 (TCF7L2) gene polymorphisms are strong predictorsof type 2 diabetes among nonobese diabetics in the Turkish population.
Erkoç Kaya D; Arikoğlu H; Kayiş SA; Öztürk O; Gönen MS
Turk J Med Sci; 2017 Feb; 47(1):22-28. PubMed ID: 28263491
[TBL] [Abstract][Full Text] [Related]
37. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
[TBL] [Abstract][Full Text] [Related]
38. Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2.
Tian L; Song Z; Shao W; Du WW; Zhao LR; Zeng K; Yang BB; Jin T
Cell Death Dis; 2017 Jan; 8(1):e2559. PubMed ID: 28102847
[TBL] [Abstract][Full Text] [Related]
39. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
40. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
